Novel Combination Therapy with Sorafenib and Propranolol for Refractory Lymphangioma Circumscriptum

Indian Dermatology Online Journal 2026 Open access

Read full text
Authors: Anubhav Roy, Gopalsing Rameshsing Rajput, Jandhyala Sridhar, Amol Patel
DOI: 10.4103/idoj.idoj_272_25
Cited by: 0
References: 6

Abstract

Dear Editor, Lymphangioma circumscriptum (LC) represents a superficial lymphatic malformation classified under the broader category of lymphangiomas, which are congenital hamartomatous proliferations of the lymphatic system. According to the International Society for the Study of Vascular Anomalies (ISSVA) classification, LC is categorized as a common (cystic) lymphangioma within the microcystic subtype (diameter

Fields of Study & Subjects

Vascular Malformations and Hemangiomas Lymphatic System and Diseases Lymphatic Disorders and Treatments

Publication details

Journal / source
Indian Dermatology Online Journal
Volume
17
Issue
2
Pages
255–258
Publication date
9 February 2026
Language
EN